Progress in the Application of Interventional Technique in Malignant Obstructive Jaundice

Lipeng Yang, Xingyuan Zhang, S. Fan, Xuefeng Cao
{"title":"Progress in the Application of Interventional Technique in Malignant Obstructive Jaundice","authors":"Lipeng Yang, Xingyuan Zhang, S. Fan, Xuefeng Cao","doi":"10.11648/J.IJG.20210502.14","DOIUrl":null,"url":null,"abstract":"Malignant obstructive jaundice (MOJ) is usually due to the terminal stages of tumor, so there is no time for curative surgery. Hyperbilirubinemia caused by MOJ can cause damage to systems throughout the body and affect the survival prognosis. Symptomatic treatment is needed even in the advanced stage of the disease. Interventional therapy and surgery are the main means to relieve biliary obstruction, but patients have poor tolerance to surgery at this time, and the risk of surgery is high. At this time, the focus of treatment is to remove the obstruction of the biliary tract as early as possible to avoid the further aggravation of jaundice, progressive deterioration of liver function and other serious complications. Biliary interventional therapy has the special advantage of minimally invasive, and is an effective treatment for patients with advanced MOJ. Currently, bile duct interventional therapy mainly includes bile duct interventional drainage, biliary stent implantation, iodine-125 (125 I) seed strand implantation, biliary radiofrequency ablation(RFA)and Intraluminal brachytherapy (ILBT), etc. Each of which has its own advantages and disadvantages in clinical application. With the progress of medical technology and the improvement and perfection of hardware equipment, the combination of multiple clinical departments and multiple operation methods will become a new trend of MOJ interventional therapy.","PeriodicalId":246347,"journal":{"name":"International Journal of Gastroenterology","volume":"41 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Gastroenterology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11648/J.IJG.20210502.14","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Malignant obstructive jaundice (MOJ) is usually due to the terminal stages of tumor, so there is no time for curative surgery. Hyperbilirubinemia caused by MOJ can cause damage to systems throughout the body and affect the survival prognosis. Symptomatic treatment is needed even in the advanced stage of the disease. Interventional therapy and surgery are the main means to relieve biliary obstruction, but patients have poor tolerance to surgery at this time, and the risk of surgery is high. At this time, the focus of treatment is to remove the obstruction of the biliary tract as early as possible to avoid the further aggravation of jaundice, progressive deterioration of liver function and other serious complications. Biliary interventional therapy has the special advantage of minimally invasive, and is an effective treatment for patients with advanced MOJ. Currently, bile duct interventional therapy mainly includes bile duct interventional drainage, biliary stent implantation, iodine-125 (125 I) seed strand implantation, biliary radiofrequency ablation(RFA)and Intraluminal brachytherapy (ILBT), etc. Each of which has its own advantages and disadvantages in clinical application. With the progress of medical technology and the improvement and perfection of hardware equipment, the combination of multiple clinical departments and multiple operation methods will become a new trend of MOJ interventional therapy.
恶性梗阻性黄疸介入技术的应用进展
恶性梗阻性黄疸(MOJ)通常是由于肿瘤晚期,因此没有时间进行手术治疗。MOJ引起的高胆红素血症可对全身系统造成损害,影响生存预后。即使在疾病的晚期,也需要对症治疗。介入治疗和手术是缓解胆道梗阻的主要手段,但此时患者对手术的耐受性差,手术风险高。此时治疗的重点是尽早清除胆道梗阻,避免黄疸进一步加重,肝功能进行性恶化等严重并发症。胆道介入治疗具有微创的特殊优势,是晚期MOJ患者的有效治疗方法。目前,胆管介入治疗主要包括胆管介入引流、胆道支架植入、碘-125 (125 I)粒子束植入、胆道射频消融(RFA)、腔内近距离放射治疗(ILBT)等。每种方法在临床应用中都有各自的优缺点。随着医疗技术的进步和硬件设备的改进与完善,多临床科室、多手术方式的结合将成为MOJ介入治疗的新趋势。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信